Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
Frontiers in Oncology
|
January 1, 2025
Obinutuzumab-induced acute thrombocytopenia: a case report and literature review
Xuelin Dou, Kongyang Li, Jin Lu
The Oncologist
|
June 13, 2019
Planned Pregnancy in Female Patients with Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitor Therapy
Xuelin Dou, Yazhen Qin, Xiaojun Huang, et al.
Science China. Life Sciences
|
July 27, 2013
Translational medicine in China: awareness is increasing and research is advancing
Xuelin Dou, Zhili Cao, Hongyan Ying, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 27, 2020
Comparable Efficacy and Safety of Generic Imatinib and Branded Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia With a Consideration of Socioeconomic Characteristics: A Retrospective Study From a Single Center
Xuelin Dou, Yazhen Qin, Yueyun Lai, et al.
Annals of Hematology
|
October 31, 2024
Using machine learning approaches to develop a fast and easy-to-perform diagnostic tool for patients with light chain amyloidosis: a retrospective real-world study
Yang Liu, Xuelin Dou, Xiaojing Yan, et al.
Journal of Clinical Medicine
|
December 9, 2023
Prognostic Value of Holter Monitoring in Light Chain Amyloidosis
Yutong Sun, Qinghao Zhao, Yang Liu, et al.
Annals of Hematology
|
November 11, 2024
Early dFLC response by C1D7 predicts complete hematologic response in systemic AL amyloidosis
Yang Liu, Jingyi Bi, Xuelin Dou, et al.
JMIR Formative Research
|
November 2, 2023
Patient Journey Toward a Diagnosis of Light Chain Amyloidosis in a National Sample: Cross-Sectional Web-Based Study
Xuelin Dou, Yang Liu, Aijun Liao, et al.
Journal of Cancer Research and Clinical Oncology
|
April 9, 2021
Impact of socio-demographic co-variates on prognosis, tyrosine kinase-inhibitor use and outcomes in persons with newly-diagnosed chronic myeloid leukaemia
Lu Yu, Huifang Wang, Robert Peter Gale, et al.
Cancer Letters
|
January 4, 2025
The burden of multiple myeloma in China: Trends from 1990 to 2021 and forecasts for 2050
Xuelin Dou, Guixiang Duan, Yanting Zhong, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
Frontiers in Oncology
|
January 1, 2025
Obinutuzumab-induced acute thrombocytopenia: a case report and literature review
Xuelin Dou, Kongyang Li, Jin Lu
The Oncologist
|
June 13, 2019
Planned Pregnancy in Female Patients with Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitor Therapy
Xuelin Dou, Yazhen Qin, Xiaojun Huang, et al.
Science China. Life Sciences
|
July 27, 2013
Translational medicine in China: awareness is increasing and research is advancing
Xuelin Dou, Zhili Cao, Hongyan Ying, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 27, 2020
Comparable Efficacy and Safety of Generic Imatinib and Branded Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia With a Consideration of Socioeconomic Characteristics: A Retrospective Study From a Single Center
Xuelin Dou, Yazhen Qin, Yueyun Lai, et al.
Annals of Hematology
|
October 31, 2024
Using machine learning approaches to develop a fast and easy-to-perform diagnostic tool for patients with light chain amyloidosis: a retrospective real-world study
Yang Liu, Xuelin Dou, Xiaojing Yan, et al.
Journal of Clinical Medicine
|
December 9, 2023
Prognostic Value of Holter Monitoring in Light Chain Amyloidosis
Yutong Sun, Qinghao Zhao, Yang Liu, et al.
Annals of Hematology
|
November 11, 2024
Early dFLC response by C1D7 predicts complete hematologic response in systemic AL amyloidosis
Yang Liu, Jingyi Bi, Xuelin Dou, et al.
JMIR Formative Research
|
November 2, 2023
Patient Journey Toward a Diagnosis of Light Chain Amyloidosis in a National Sample: Cross-Sectional Web-Based Study
Xuelin Dou, Yang Liu, Aijun Liao, et al.
Journal of Cancer Research and Clinical Oncology
|
April 9, 2021
Impact of socio-demographic co-variates on prognosis, tyrosine kinase-inhibitor use and outcomes in persons with newly-diagnosed chronic myeloid leukaemia
Lu Yu, Huifang Wang, Robert Peter Gale, et al.
Cancer Letters
|
January 4, 2025
The burden of multiple myeloma in China: Trends from 1990 to 2021 and forecasts for 2050
Xuelin Dou, Guixiang Duan, Yanting Zhong, et al.
Page
of 3